NTLA
Intellia Therapeutics, Inc. · Healthcare
VP and Chief Accounting Officer Michael P Dube sold $44K of Intellia Therapeutics, Inc.
Sold$44,316
$16.78Price
2,641Shares
−4%Stake
What NTLA did after the filing
- The stock from Tue, Jul 7 open, $17.85
- −25.6%
- S&P 500, same days
- +2.5%
Measured over 30 trading days, to the Aug 19 close.
Traded Wed, Jul 1. Filed Mon, Jul 6, 5:02 PM ET, after the close. Returns use the Jul 7 open and the Aug 19 close. Not investment advice.